← All trials
NCT02289027
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2014
- Primary completion
- Jun 1, 2015
- Completion date
- Jun 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 5 / —
- Source
- AACT · pre-existing
Sponsors
- University of LausanneLead sponsor
- University of LausanneOverall official - principal investigator
- Policlinique Médicale UniversitaireCollaborator
- University of LausanneCollaborator
- GlaxoSmithKlineCollaborator
- World Health OrganizationCollaborator
- University of LausanneReponsible party - principal investigator
- University of BaselCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.